Arrhythmias & electrophysiology

Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial

CirculationPublished Randomised controlled trial

Authors' conclusion

The PRAETORIAN-XL trial demonstrated that there was no significant difference between the S-ICD and TV-ICD in all device-related complications during long-term follow-up. However, the TV-ICD carries a higher risk of major and lead-related complications compared with S-ICD therapy.

Study context

Population
Patients with a class I or IIa indication for ICD therapy without need for pacing, 39 centres in the US and Europe, 2011–2017
Participants
426 vs 423
Comparison
Subcutaneous implantable cardioverter defibrillator (S-ICD) vs transvenous ICD (TV-ICD)
  • S-ICDn = 426
  • TV-ICDn = 423reference
Primary endpoint
Composite of all device-related complications
Follow-up
Median 87.5 months
Methodological detailslong-term follow-up extension of the PRAETORIAN trial, multicentre, superiority, modified intention-to-treat, as-treated analysis
  • Long-term follow-up extension of the PRAETORIAN trial
  • Multicentre
  • Superiority
  • Modified intention-to-treat
  • As-treated analysis

Primary result

As reported in the abstract

All device-related complications (major and minor combined)

All device-related complications not significantly different

subdistribution HR 0.73 (0.48-1.12); P=0.15 (95% CI)

Further findings

OutcomeHR (95% CI)P value
All device-related complications, as-treated analysis · significantly more complications with TV-ICD · as-treated · Cox model, device type time-dependent0.64 (0.41–0.99)P = 0.047

Major complications; lead-related complications

Major complications more often with TV-ICD
P = 0.03
Lead-related complications more often with TV-ICD
P < 0.001

Original publication

Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial. Circulation. Published 25 April 2025. doi:10.1161/circulationaha.125.074576

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.